CYPHERMEDICAL.COM Trademark

Trademark Overview


On Wednesday, February 7, 2024, a trademark application was filed for CYPHERMEDICAL.COM with the United States Patent and Trademark Office. The USPTO has given the CYPHERMEDICAL.COM trademark a serial number of 98396453. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, August 2, 2024. This trademark is owned by Cypher Medical, LLC. The CYPHERMEDICAL.COM trademark is filed in the Advertising, Business and Retail Services category with the following description:

Website for use in marketing and sales of red blood cell sedimentation and/or red blood cell accumulation measurement and materials for providing same
cyphermedical.com

General Information


Serial Number98396453
Word MarkCYPHERMEDICAL.COM
Filing DateWednesday, February 7, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, August 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCYPHER MEDICAL
Goods and ServicesWebsite for use in marketing and sales of red blood cell sedimentation and/or red blood cell accumulation measurement and materials for providing same

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, February 7, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCypher Medical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBandera, TX 78003

Trademark Events


Event DateEvent Description
Wednesday, February 7, 2024NEW APPLICATION ENTERED
Thursday, June 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 2, 2024ASSIGNED TO EXAMINER
Friday, August 2, 2024NON-FINAL ACTION E-MAILED
Friday, August 2, 2024NON-FINAL ACTION WRITTEN